News & Insights

News & Insights

What to Expect from a Third-Party Logistics (3PL) Company

What to Expect from a Third-Party Logistics (3PL) Company


3PLs are defined as an organization that provides logistics services such as, warehousing, distribution, customer and financial services on behalf of a biopharmaceutical company. 3PLs play a critical role in the success of biopharmaceutical companies and...

Andrew Kirk, Chief Revenue Officer at BioCare, provides insights on “Leveraging The Expertise Of Your Board”


A company's board of directors plays a vital role in shaping its direction and success. Engaging the expertise of board members effectively can be a game-changer for any organization. Over the last 20 years, I have...

Recognizing Rare Disease Day


Rare Disease Day is dedicated to solidarity and raising awareness of the rare diseases that affect about 300 million people worldwide. It’s observed on February 29th, the rarest date possible…but in non-leap years, such as 2023,...

Industry Insights: The Evolution of the Manufacturer & Specialty Distributor Relationship

Industry Insights: The Evolution of the Manufacturer & Specialty Distributor Relationship


As we look ahead, it’s clear that specialty therapies will continue to expand within the industry. For manufacturers, this could mean reconsidering the specialty distributor you work with and for specialty distributors, this might mean reassessing...

Kevin Kissling, Vice President/General Manager of 3PL Services at LogiCare3PL, on “Peeking Behind the Curtain: The Current State of Pharma 3PLs and Future Outlook”


Third-party logistics (3PL) providers are often called upon by pharmaceutical manufacturers to help address the challenges surrounding the movement and distribution of medicines; their importance in helping to simplify the pharma supply chain does not go...

FDA-Approved RENFLEXIS for Treatment of Multiple Autoimmune Diseases Now Distributed by BioCareSD


BioCareSD, a leading specialty distributor for orphan, rare and ultra-rare diseases, announced today that they have added RENFLEXIS, a biosimilar to REMICADE, to their ever-expanding portfolio of therapies...

Andrew Kirk, Chief Revenue Officer at BioCare, on “How Leaders And Managers Can Become Better Mentors”


In the fast-paced world of business, where leaders and managers are at the forefront of organizational success, the distinction between being a manager or leader and being a mentor is a subtle yet essential one. Leaders...

The Drug Supply Chain Security Act (DSCSA) & How Companies Can Prepare for Compliance


DSCSA Compliance with a Trusted Partner Don’t have time to comb through long and complicated FDA guidance documents on the Drug Supply Chain Security Act (DSCSA) and want a ‘CliffsNotes’ version? This white paper shapes and summarizes...

BioCare In-House Expertise to Guide Customers on Effectively Preparing for the Drug Supply Chain Security Act (DSCSA)


BioCare today released a white paper on the Drug Supply Chain Security Act (DSCSA) and how companies can prepare for compliance with the U.S. Food and Drug Administration's (FDA) requirements to ensure all medications are genuine, uncontaminated,...

The Drug Supply Chain Security Act (DSCSA) & How Companies Can Prepare For Compliance

The Drug Supply Chain Security Act (DSCSA) & How Companies Can Prepare For Compliance


These new regulations can seem overwhelming – and understandably so. This places more importance on trusted partners to share their knowledge and expertise in order to maintain a successful transition. In the end, meeting DSCSA compliance...